The Impact on Patients and Specialty Pharmacies of Evolving
Payer Interventions to Manage Hepatitis C Agents
Tucker Hurtado, MPH
Fionna Frascella, BS
Health Strategies Group
The authors report no financial conflicts with any products discussed in this paper.
Management of Hepatitis C
Treatments is a Top Priority
The approval of considerably improved therapies
for hepatitis C has radically changed the treatment
paradigm for patients while significantly increasing
drug expenditures for payers. The nee